I run a men's health clinic in Providence where we treat low testosterone, erectile dysfunction, and related cardiometabolic issues. At Men's Health Boston before opening my practice, we saw thousands of patients annually and consistently tracked how testosterone optimization, weight management, and lifestyle changes affected cardiovascular markers--so I've watched the intersection of hormones and heart health play out in real time. The vitamin D3 finding makes sense from what we see clinically. Many of our patients with low testosterone also show vitamin D deficiency on labs, and both independently correlate with worse cardiovascular outcomes. When we correct vitamin D alongside testosterone therapy and push patients toward better nutrition and exercise, their lipid panels improve, inflammation markers drop, and they report feeling stronger--all of which should theoretically lower cardiac event risk. That said, one study showing a 50% reduction is impressive but needs replication across larger populations before I'd call it definitive. Vitamin D is cheap and low-risk, so supplementing post-MI makes sense as part of a broader recovery plan, but it's not a silver bullet--you still need the fundamentals like medication adherence, stress management, and regular cardiology follow-up. I'd want to see the study's dosing protocol, patient demographics, and whether they controlled for other interventions before recommending a specific regimen to my patients. My credentials are at cmh-ri.com/pharmacy-info/ where I'm listed as Leonard Berkowitz, PA-C, co-founder and licensed provider with hospital privileges at Miriam Hospital in Providence.